4//SEC Filing
PETERS KEVIN G. 4
Accession 0000899243-20-008922
CIK 0001422142other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 6:10 PM ET
Size
10.0 KB
Accession
0000899243-20-008922
Insider Transaction Report
Form 4
PETERS KEVIN G.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-03-16+129,000→ 129,000 totalExercise: $0.52Exp: 2030-03-16→ Common Stock (129,000 underlying)
Footnotes (1)
- [F1]Options exercisable as to 1/4th on March 16, 2021 and an additional 1/48th monthly thereafter until March 16, 2024.
Issuer
Aerpio Pharmaceuticals, Inc.
CIK 0001422142
Entity typeother
Related Parties
1- filerCIK 0001700663
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 6:10 PM ET
- Size
- 10.0 KB